Font Size: a A A
Keyword [KRAS mutation]
Result: 1 - 20 | Page: 1 of 3
1. Screening Of Differentially Experssed Proteins In Pancreatic Cancer And Protein Expressed In Pancreatic Cancer With Kras Mutation
2. Tumor Tissue And Plasma Kras Mutations And The Prognosis Of Patients With Colorectal Cancer Study
3. The Research Of STK33 Gene And KRAS Gene And EGFR Gene Expression In Lung Cancer
4. Detection Of KRAS Mutation And Advanced Colorectal Cancer Targeting Prognosis Assessment
5. Exploration Of New Therapeutic Targets For The Treatment Of Non-small Cell Lung Cancer
6. Synergistic Function Of Kras Mutation And HBx In Initiation And Progression Of Hepatocellular Carcinoma In Mice
7. Studies On The Establishment And Clinical Application Of Detection For Free DNA KRAS Mutation In The Peripheral Blood
8. Analysis Of Oncogenic Driver Mutations In Lung Squamous-Cell Carcinoma From Chinese Population
9. Malignant Potential Mechanisms And EGFR、KRAS Mutation In Pulmonary Micropapillary Adenocarcinoma
10. Comparison Of The Efficacy Of TKI In Patients Diagnosed With Advanced Lung Adenocarcinoma, Harboring Different EGFR, KRAS Mutation Status
11. Delivery Of Small Interfering RNA With Micelleplex From Polymer Micelles For Cancer Therapy
12. Effect Of Genomic Instability And Mutations On The Signaling Network In Colon Cancer Cells
13. Expression Of REDD1and Its Correlations With Ras Mutation And PI3K/AKT Signaling Pathway In Ovarian Cancer
14. 1、The Molecular Mechanism Of The Up-regulated Expression Of DLK1 Gene In Lung Cancer 2、Study On Heterogeneity Of EGFR/KRAS Mutation In Multifocal Lung Adenocarcinoma
15. Characterization Of Macropinocytosis Structures Of Kras Mutant Pancreatic Cancer Cells And Internalization Of Mesoporous Silica Nanoparticles (MSNs) Into Pancreatic Cancer Cells As Anticancer Drug Delivery Devices
16. Potential Predictive Value Of TP53 And KRAS Mutation To PD-1 Blockade Immunotherapy In Lung Adenocarcinoma
17. The Mechanism Of Downregulation Of Pancreatic FGF21 By KrasG12D In Initiation Of Pancreatic Cancer
18. Targeting Telomerase Is The New Strategy Of Non-small Cell Lung Cancer With KRAS Mutation
19. Taqman Probe Couple With DNA-binding Dye Based COLD-PCR Enables Rapid Screening Of Low Abundance KRAS Mutation In Blood
20. Association Between The KRAS Status And The Efficacy Of First-line Chemotherapy In Patients With Advanced Non-small Cell Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to